retatrutide news today october 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation Retatrutide: FDA approval time, trial

The PSPeptides Reconstitution Toolkit A unique advantage for researchers switching from Swiss Chems: PSPeptides offers a free peptide reconstitution calculator and video an advanced dosing tool with a visual syringe diagram showing exactly how many units to draw, plus a video guide demonstrating the entire reconstitution technique

Dhar, D

This compares to a combined total of less than 500 listings removed across the previous two years.

Novo Nordisk recently pulled out of a $10 billion bidding war with Pfizer for Metsera arguably an attempt to regain dominance in the lucrative obesity drug market through acquisition of further weight loss drug brands even though the treatments from Metsera could still be years away from hitting shelves

Brightening | For Chapped, Dry Lips lipbam